Skip to main content

Table 4 Incidence of acute kidney injury in critically ill pH1N1 patients using different definitions of baseline renal function

From: Acute kidney injury among critically ill patients with pandemic H1N1 influenza A in Canada: cohort study

Primary analysis, with baseline glomerular filtration rate estimated as 75 ml/min/1.73 m2

Incidence

Hospital mortality1, 2

(n = 562)

No AKI

220 (39.1)

28/216 (13.0)

   None

181 (32.2)

21/178 (11.8)

   Risk

39 (6.9)

7/38 (18.4)

AKI

342 (60.9)

85/329 (25.8)

   Injury

129 (23.0)

20/125 (16.0)

   Failure

213 (37.9)

65/204 (31.9)

Renal replacement therapy, n = 561

85 (15.1)

26/84 (31.0)

   Injury

3 (0.5%)

3/3 (100)

   Failure

82 (14.6%)

26/81 (31.0%)

Sensitivity analysis 1, assuming that first available serum creatinine is the baseline

n = 537

 

No AKI

269 (50.1)

45/262 (17.2)

   None

221 (41.2)

26/217 (12.0)

   Risk

48 (8.9)

19/45 (42.2)

AKI

268 (49.9)

64/259 (24.7)

   Injury

253 (47.1)

61/244 (25.0)

   Failure

15 (2.8)

3/15 (20.0)

Sensitivity analysis 2, assuming that lowest observed serum creatinine at any time is the baseline

n = 562

 

No AKI

218 (38.8)

27/214 (12.6)

   None

194 (34.5%)

25/191 (13.1)

   Risk

24 (4.2%)

2/23 (8.7)

AKI

344 (61.2)

86/331 (26.0)

   Injury

118 (21.0%)

15/114 (13.2)

   Failure3

226 (40.2%)

71/217 (32.7)

  1. Data are presented as n (%).
  2. 1 Denominators differ from the incidence column due to missing survival status (17/562 patients).
  3. 2 In the primary analysis, mortality differed significantly across the 4 RIFLE categories of None, Risk, Injury, and Failure (p < 0.0001) and across the categories of Risk, Injury, and Failure (p = 0.003).
  4. 3 For this analysis, patients who received RRT are assumed to have ‘Failure’.